@article{7b31960c38b14fbba7c9164b9d66dad6,
title = "From the pages of AllergyWatch",
author = "Stanley Fineman and Shyam Joshi and Vivian Hernandez-Trujillo",
note = "Funding Information: Disclosures: Dr Fineman serves as a clinical investigator for Aimmune Therapeutics, Inc, Biocryst Pharmaceuticals, Inc, DBV, and Regeneron and as a speaker/teacher for Takeda. Dr Joshi serves as an advisory board member of GlaxoSmithKline and as a speaker/teacher for PRIME Education, LLC. Dr Hernandez-Trujillo serves as a consultant/advisor for CSL Behring; reports receiving honoraria from Bayer, Meda, and Merck; and research funding from CSL Behring. Funding: The authors have no funding sources to report. Funding Information: Disclosures: Dr Fineman serves as a clinical investigator for Aimmune Therapeutics, Inc, Biocryst Pharmaceuticals, Inc, DBV, and Regeneron and as a speaker/teacher for Takeda. Dr Joshi serves as an advisory board member of GlaxoSmithKline and as a speaker/teacher for PRIME Education, LLC. Dr Hernandez-Trujillo serves as a consultant/advisor for CSL Behring; reports receiving honoraria from Bayer, Meda, and Merck; and research funding from CSL Behring. ",
year = "2022",
month = may,
doi = "10.1016/j.anai.2022.02.011",
language = "English (US)",
volume = "128",
pages = "613--614",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "5",
}